::::::::::

GFREI Public Consultation Submission at 22 July 2023 :: WHO Guidance for Global Practices for Clinical Trials – Draft (19 July 2023)

Alternative Citations [APA]:

GE2P2 Global Foundation on behalf of the Global Forum on Research Ethics and Integrity [GFREI] Working Group. (22 September 2023). GFREI Public Consultation Submission: WHO Guidance for Global Practices for Clinical Trials – Draft. (19 July 2023). https://wordpress.com/page/ge2p2-center.net/22742

Curry, D.R., Adiabu, S.,  MPH, Doe Anderson, J., Andrade-Narvaez, F.J., Ang, L., Arawi, T., Aurich, B., DeTora, L., Diniz, N., Gispen-de Wied, C.C., Klein, R., Mahasha, P.W., Pavlov, C.S., Redman, B., Schatz, G.S., Sitorus, R.S., Suzuki, M. as the Global Forum on Research Ethics and Integrity [GFREI] Working Group/GE2P2 Global Foundation. (22 September 2023). GFREI Public Consultation Submission: WHO Guidance for Global Practices for Clinical Trials – Draft. (19 July 2023). https://wordpress.com/page/ge2p2-center.net/22742

::::::::::

GFREI Public Consultation Submission at 05 September 2023 :: ICH E6(R3) GCP  Principles, Annex 1 – Draft (19 May 2023)

Alternative Citations [APA]:

GE2P2 Global Foundation on behalf of the Global Forum on Research Ethics and Integrity [GFREI] Working Group. (05 September 2023). GFREI Public Consultation Submission: ICH E6(R3) GCP  Principles, Annex 1 – Draft. (19 May 2023). https://wordpress.com/page/ge2p2-center.net/22763 FDA Posted Version: https://www.regulations.gov/comment/FDA-2023-D-1955-0041

Curry, D.R., Adiabu, S., Andrade-Narvaez, F.J., Ang, L., Asif, F., Arawi, T., Aurich, Bierer, B.E., Collet, M.C., DeTora, L., Diniz, N.M., Gispen-de Wied, C.C., Kang, J.S., Klein, R., Kumar, N.,  Mahasha, P.W., Pavlov, C.S., Redman, B., Ross, G., Schatz, G.S., Sitorus, R.S., as the Global Forum on Research Ethics and Integrity [GFREI] Working Group/GE2P2 Global Foundation. (05 September 2023). GFREI Public Consultation Submission: ICH E6(R3) GCP  Principles, Annex 1 – Draft. (19 May 20), https://wordpress.com/page/ge2p2-center.net/22763 FDA Posted Version: https://www.regulations.gov/comment/FDA-2023-D-1955-0041

::::::::::

GFREI RFI Submission at 03 August 2022: NIH Promoting Equity in Global Health Research, NOT-TW-22-001 – Draft (May 20, 2022)

Alternative Citations [APA]:

GE2P2 Global Foundation on behalf of the Global Forum on Research Ethics and Integrity [GFREI] Working Group. (03 August 2022). GFREI RFI Submission: NIH Promoting Equity in Global Health Research, NOT-TW-22-001 – May 20, 2022 https://wordpress.com/page/ge2p2-center.net/22778

Curry, D.R., Adiabu, S., Andrade-Narvaez, F.J., Ang, L., Arawi, T., Asif, F., Aurich, B., Bierer, B.E., Bukini, D.A., Crawley, F.P., Dalla Costa, E., Diniz, N.M., Dobrova, V., Engler-Todd, Freitas, M., Hassan, M. Iceland, K., Ike, C., Kebede, S., Kumar, N., Kurihara, C., Lolas, F., Mboera, L., Muthuswamy, V., Pavlov, C.S., Prichep, E., Ross, G., Sitorus, R.S., Su, Y., Suzuki, M., Ukpong-Folayan, M., Yimer, G. as the Global Forum on Research Ethics and Integrity [GFREI] Working Group/GE2P2 Global Foundation. (03 August 2022). GFREI RFI Submission: NIH Promoting Equity in Global Health Research, NOT-TW-22-001 – May 20, 2022. https://wordpress.com/page/ge2p2-center.net/22778

::::::::::

GFREI Public Consultation Submission at 11 April 2022: CIOMS Working Group XI draft report – Patient Involvement in the development, regulation and safe use of medicines – Draft (28 Feb 2022)

Alternative Citations [APA]:

GE2P2 Global Foundation on behalf of the Global Forum on Research Ethics and Integrity [GFREI] Working Group. (11 April 2022.  GFREI Public Consultation Submission: CIOMS Working Group XI draft report – Patient Involvement in the development, regulation and safe use of medicines, 28 February 2022.  https://wordpress.com/page/ge2p2-center.net/22737

Curry, D.R., Arawi, T., Aurich, B., Schatz, G.A., Su, Y., as the Global Forum on Research Ethics and Integrity [GFREI] Working Group/GE2P2 Global Foundation(11 April 2022.  GFREI Public Consultation Submission: CIOMS Working Group XI draft report – Patient Involvement in the development, regulation and safe use of medicines, 28 February 2022. https://wordpress.com/page/ge2p2-center.net/22737

::::::::::

::::::::::

::::::::::

::::::::::

::::::::::